手术与比药物治疗肥胖症更好的长期结果有关:系统性审查和元分析
相关实验视频
Updated: Jun 27, 2025
04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
371
Leonardo Zumerkorn Pipek1, Walter Augusto Fabio Moraes2, Rodrigo Massato Nobetani2
1Department of Neurology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil.
Scientific reports
|April 25, 2024
概括
与密集医疗治疗相比,减肥手术在治疗肥胖症方面提供了更好的长期结果. 手术干预显著改善体重减轻,心血管健康和内分泌标志物,显示出更好的整体临床结果.
科学领域:
- 代谢和腹部手术 代谢和腹部手术
- 肥胖医学 肥胖医学
- 心血管健康 心血管健康
背景情况:
- 肥胖是一种常见的慢性疾病,具有严重的健康并发症.
- 目前的治疗方案包括密集医学治疗和减肥手术.
- 长期的比较疗效数据对于治疗决策至关重要.
研究的目的:
- 为了比较密集医疗治疗与肥胖症减肥手术的长期疗效.
- 评估12个关键参数,包括减肥,心血管和内分泌变化.
- 通过元分析综合随机对照试验的证据.
主要方法:
- 按照PRISMA指南进行的系统文献审查 (PROSPERO:CRD42021265637).
- 在PubMed,EMBASE和Web of Science数据库中搜索到2023年10月.
- 包括随机对照试验,比较医疗和手术肥胖干预措施;使用RoB2.2评估偏差风险.
主要成果:
- 六项随机对照试验的元分析,涉及427名患者;随访时间长达10年.
- 腹腔外科手术在减肥,总胆固醇,甘油三,高血压,静脉和腹腔血压,HbA1c,HOMA-IR和心血管风险方面表现出优异的长期结果.
- 两组治疗对大多数参数都显示出统计学意义,但手术带来了更大的改善.
结论:
- 腹部外科手术在肥胖管理方面提供了优越的长期临床结果,与强化医疗治疗相比.
- 手术干预显著影响主要的代谢和心血管健康指标.
- 这一元分析支持减肥手术作为持续肥胖管理的高效选择.
相关概念视频
01:30Psychosurgery
54
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
54
01:15Diabetes: Management and Pharmacotherapy
268
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
268